Effectiveness of subcutaneous injections of a cartilage preparation in osteoarthritis of the knee-A randomized, placebo controlled phase II study

Complementary Therapies in Medicine

Volumn 18, Issue 3-4, 2010, Pages 113-118

  Huber, Roman ^a   Prestel, Ute ^a   Bloss, Isabel ^a   Meyer, Ulrich ^b   Lüdtke, Rainer ^c  

^a UNIVERSITY OF FREIBURG   (Germany)

^b WALA HEILMITTEL GMBH   (Germany)

^c Karl und Veronica Carstens Stiftung   (Germany)

Author keywords

Anthroposophic medicine; Organ preparation; Osteoarthritis; Randomized controlled trial; WOMAC

Indexed keywords

ARTICULATIO GENUS D5; NATURAL PRODUCT; NONSTEROID ANTIINFLAMMATORY AGENT; PLACEBO; UNCLASSIFIED DRUG;

ADULT; AGED; ANALGESIA; ARTICLE; ARTICULAR CARTILAGE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFICACY; FEMALE; HUMAN; INJECTION SITE IRRITATION; JOINT STIFFNESS; KNEE FUNCTION; KNEE OSTEOARTHRITIS; MAJOR CLINICAL STUDY; MALE; PAIN ASSESSMENT; PHASE 2 CLINICAL TRIAL; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; TREATMENT OUTCOME; WESTERN ONTARIO AND MC MASTERS UNIVERSITY ARTHRITIS INDEX;

AGED; ANIMALS; BIOLOGICAL PRODUCTS; CARTILAGE; CATTLE; DOUBLE-BLIND METHOD; FEMALE; HUMANS; INJECTIONS, SUBCUTANEOUS; MALE; MIDDLE AGED; OSTEOARTHRITIS, KNEE; PAIN; TREATMENT OUTCOME;

EID: 77955323373     PISSN: 09652299     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ctim.2010.06.001     Document Type: Article

References (28)

1. Engelhardt M. Epidemiology of osteoarthritis in Western Europe. Dtsch Z Sportmed 2003, 54(6):171-173.
2. Sprangers M.A., de Regt E.B., Andries F., van Agt H.M., Bijl R.V., de Boer J.B., et al. Which chronic conditions are associated with better or poorer quality of life?. J Clin Epidemiol 2000, 53(9):895-907.
3. Kessler S. Behandlungsstrategien der Gonarthrose. Med Welt 2003, 54:12-17.
4. Gurwitz J.H., Avorn J. The ambiguous relation between aging and adverse drug reactions. Ann Intern Med 1991, 114(11):956-966.
5. Tramèr M.R., Moore R.A., Reynolds D.J., McQuay H.J. Quantitative estimation of rare adverse events which follow a biological progression: a new model applied to chronic NSAID use. Pain 2000, 85(1-2):169-182.
6. Felson D.T. The sources of pain in knee osteoarthritis. Curr Opin Rheumatol 2005, 17(5):624-628.
7. Felson D.T. Developments in the clinical understanding of osteoarthritis. Arthritis Res Ther 2009, 11(1):203.
8. Sulzbacher I. Arthrosis-histology and pathogenetic approaches. Radiologe 2000, 40(12):1126-1133.
9. Fishkin Z., Miller D., Ritter C., Ziv I. Changes in human knee ligament stiffness secondary to osteoarthritis. J Orthop Res 2002, 20(2):204-207.
10. Slobodin G., Rozenbaum M., Boulman N., Rosner I. Varied presentations of enthesopathy. Semin Arthritis Rheum 2007, 37(2):119-126.
11. Weiler H.T., Pap G., Awiszus F. The role of joint afferents in sensory processing in osteoarthritic knees. Rheumatology (Oxford) 2000, 39(8):850-856.
12. Bajaj P., Bajaj P., Graven-Nielsen T., Arendt-Nielsen L. Osteoarthritis and its association with muscle hyperalgesia: an experimental controlled study. Pain 2001, 93(2):107-114.
13. Scott N.A., Guo B., Barton P.M., Gerwin R.D. Trigger point injections for chronic non-malignant musculoskeletal pain: a systematic review. Pain Med 2009, 10(1):54-69.
14. Sickel K. Plenosol in the treatment of arthrotic changes. Z Allgemeinmed 1971, 47(31):1667-1669.
15. Roemer F., Roggatz M., Soldner G., Sommer M., Vogel HH Anthroposophische Medizin in der Praxis 2 2002, Natur Mensch Medizin Verlags GmbH Bad Boll. 1st ed.
16. Barron M.C., Rubin B.R. Managing osteoarthritic knee pain. J Am Osteopath Assoc 2007, 107(10 Suppl. 6):ES21-ES27.
17. Roemer F., Sommer M. Zur Bedeutung der potenzierten Organpräparate in der anthroposophischen Therapierichtung 1999, Der Merkurstab, Sonderheft: 2-5.
18. Roemer F. Kasuistik fortgeschrittene Valgusgonarthrose 1999, Der Merkurstab, Sonderheft: 33-34.
19. Roemer F. Kasuistik entzündlicher Reizzustand mit massivem Kniegelenkserguss auf der Grundlage einer Gonarthrose 1999, Der Merkurstab, Sonderheft: 35.
20. Bellamy N., Buchanan W.W., Goldsmith C.H., Campbell J., Stitt L.W. Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee. J Rheumatol 1988, 15(12):1833-1840.
21. Stucki G., Meier D., Stucki S., Michel B.A., Tyndall A.G., Dick W., et al. Evaluation of a German version of WOMAC (Western Ontario and McMaster Universities) Arthrosis Index. Z Rheumatol 1996, 55(1):40-49.
22. Scharf H.P., Mansmann U., Streitberger K., Witte S., Krämer J., Maier C., et al. Acupuncture and knee osteoarthritis: a three-armed randomized trial. Ann Intern Med 2006, 145(1):12-20.
23. Witt C., Brinkhaus B., Jena S., Linde K., Streng A., Wagenpfeil S., et al. Acupuncture in patients with osteoarthritis of the knee: a randomised trial. Lancet 2005, 366(9480):136-143.
24. Tannenbaum H., Berenbaum F., Reginster J.Y., Zacher J., Robinson J., Poor G., et al. Lumiracoxib is effective in the treatment of osteoarthritis of the knee: a 13 week, randomised, double blind study versus placebo and celecoxib. Ann Rheum Dis 2004, 63(11):1419-1426.
25. Pincus T., Koch G., Lei H., Mangal B., Sokka T., Moskowitz R., et al. Patient preference for placebo. Acetaminophen (paracetamol) or Celecoxib Efficacy Studies (PACES): two randomised, double blind, placebo controlled, crossover clinical trials in patients with knee or hip osteoarthritis. Ann Rheum Dis 2004, 63(8):931-939.
26. Raynauld J.P., Buckland-Wright C., Ward R., Choquette D., Haraoui B., Martel-Pelletier J., et al. Safety and efficacy of long-term intraarticular steroid injections in osteoarthritis of the knee: a randomized, double-blind, placebo-controlled trial. Arthritis Rheum 2003, 48(2):370-377.
27. Karlsson J., Sjögren L.S., Lohmander L.S. Comparison of two hyaluronan drugs and placebo in patients with knee osteoarthritis. A controlled, randomized, double-blind, parallel-design multicentre study. Rheumatology (Oxford) 2002, 41(11):1240-1248.
28. de Craen A.J., Tijssen J.G., de Gans J., Kleijnen J. Placebo effect in the acute treatment of migraine: subcutaneous placebos are better than oral placebos. J Neurol 2000, 247(3):183-188.